2026 Healthcare Safety 
Infuse Medical
JULY 4, 2024
VR in healthcare is doing magic by transforming the conventional working environment to the next level. Brief Overview of the Importance of Medical Device Maintenance Medical device maintenance ensures patient safety, operational efficiency, and regulatory compliance in healthcare settings. What is VR Training?
pharmaphorum
OCTOBER 14, 2022
The four devices will be put through their paces in real-world healthcare settings via pilot projects in Norway, Belgium, Slovenia, Spain, and Germany. The project started on 1 October and is scheduled to complete in September 2026. Great to have you on board @ForumWeee , we look forward to the next four years of collaboration! .”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
MARCH 24, 2023
Regulatory science refers to the scientific disciplines that are applied to the quality, safety and efficacy assessment of medicinal products. Thus, regulators needed to be ready to support the development and assessment of ever more complex medicines that increasingly deliver healthcare solutions by converging different technologies.
Pharmaceutical Technology
JULY 26, 2022
The SPAC is sponsored by a Frazier Healthcare Partners affiliate. Through an oversubscribed and upsized private investment in public equity (PIPE) led jointly by Frazier Healthcare Partners and Bain Capital Life Sciences, the combined business is expected to receive nearly $235m and funds held in the trust account of FLAC.
European Pharmaceutical Review
SEPTEMBER 26, 2023
Multiple sclerosis is a chronic condition with no cure at present and timely access to affordable, high-quality healthcare is therefore even more essential.” Both studies confirmed that the biosimilar matched the reference biologic for pharmacokinetics as well as efficacy, safety and immunogenicity.
European Pharmaceutical Review
FEBRUARY 12, 2024
The downstream process ensures cell removal, virus safety, and impurity removal. By leveraging the latest innovation in lean, agile and flexible models, the state-of-the-art site is primed to meet the always-evolving healthcare needs of populations worldwide”.
PM360
SEPTEMBER 21, 2023
Under the pathway, manufacturers can use safety and efficacy data from existing products in their applications for their own products. Starting in 2026, the provision will affect 10 Part D drugs. This increases to 15 Part D drugs in 2026, as well as 15 Part B and D drugs in 2028, and a full 20 Part B and D drugs in 2029.
Expert insights. Personalized for you.
130 
Let's personalize your content